Meloxicam Export Market Intelligence: India's 277 Suppliers Shipping to 100 Countries — TransData Nexus 2026

Q: Who are the top meloxicam exporters from India?

The top meloxicam exporters from India are: 1. UNICHEM LABORATORIES LIMITED — $141.5M (71.0% market share); 2. CIPLA LIMITED — $28.7M (14.4% market share); 3. ZYDUS LIFESCIENCES LIMITED — $6.2M (3.1% market share); 4. LUPIN LIMITED — $4.7M (2.4% market share); 5. VANTAGE INTERNATIONAL (INDIA) INC — $2.5M (1.2% market share). Together they account for 92.1% of India's total meloxicam export value.

Q: What is the total export value of meloxicam from India?

The total export value of meloxicam from India is $199.4M USD, recorded across 3,297 shipment transactions from 277 active exporters to 100 destination countries. The average shipment value is $60.5K.

Q: Which countries import meloxicam from India?

India exports meloxicam to 100 countries worldwide. The top importing countries are: UNITED STATES (86.3% share, $172.0M), SERBIA (3.0% share, $6.0M), AUSTRALIA (1.6% share, $3.1M), NIGERIA (1.5% share, $2.9M), VIETNAM (1.3% share, $2.5M). These five markets account for 93.6% of total export value.

Q: What is the HS code for meloxicam exports from India?

The primary HS code for meloxicam exports from India is 30049066. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of meloxicam exports from India?

The average unit price for meloxicam exports from India is $1.58 USD per unit, with prices ranging from $0.00 to $221.74 depending on formulation, packaging, and order volume. The total market is valued at $199.4M across 3,297 shipments.

Q: Which ports handle meloxicam exports from India?

The primary ports for meloxicam exports from India are NHAVA SHEVA SEA (INNSA1) (17.7% of shipments), JNPT/ NHAVA SHEVA SEA (11.3% of shipments), SAHAR AIR (11.2% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.4% of shipments), JNPT (7.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of meloxicam?

India is one of the world's leading exporters of meloxicam due to its large base of 277 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports meloxicam to 100 countries, demonstrating 51% global market coverage.

Q: What certifications do Indian meloxicam exporters need?

Indian meloxicam exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import meloxicam from India?

There are 566 registered buyers importing meloxicam from India, spread across 100 countries. The repeat buyer rate is 59.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top meloxicam supplier from India?

UNICHEM LABORATORIES LIMITED is the leading meloxicam exporter from India with a market share of 71.0% and total export value of $141.5M across 368 shipments. The top 5 suppliers together control 92.1% of total export value.

Suresh Sormare

Meloxicam

India Pharmaceutical Trade Intelligence

$199.4M277 Suppliers100 CountriesHS 30049066

ExportsIndia → UNITED STATES86.3%India → SERBIA3.0%

ImportsUNITED STATES → India$1.1M GERMANY → India$19.9K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Meloxicam Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Meloxicam to the World

Between 2022 and 2026, India exported $199.4M worth of meloxicam across 3,297 verified shipments to 100 countries — covering 51% of world markets in the Analgesics & Antipyretics segment. The largest destination is UNITED STATES (86.3%). UNICHEM LABORATORIES LIMITED leads with a 71.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Meloxicam export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Meloxicam export data snapshot — $199.4M · 277 exporters · 100 countriesTransData Nexus · Indian Customs Data

Top Meloxicam Exporters from India

277 active exporters · Ranked by export value

View all 277 →

Top Meloxicam Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	UNICHEM LABORATORIES LIMITED	$141.5M	368	13	71.0%
2	CIPLA LIMITED

Top Countries Importing Meloxicam from India

100 destination markets · Ranked by import value

All 100 countries →

Top Countries Importing Meloxicam from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$172.0M	86.3%
2	SERBIA	$6.0M	3.0%
3	AUSTRALIA	$3.1M	1.6%
4	NIGERIA	$2.9M	1.5%
5	VIETNAM	$2.5M	1.3%
6	TANZANIA	$1.3M	0.6%
7	IRELAND	$1.1M	0.6%
8	BRAZIL	$1.0M	0.5%
9	SOUTH AFRICA	$1.0M	0.5%
10	UNITED KINGDOM	$902.3K	0.5%

UNITED STATES is India's largest meloxicam export destination, absorbing 86.3% of total exports worth $172.0M. The top 5 importing countries — UNITED STATES, SERBIA, AUSTRALIA, NIGERIA, VIETNAM — together account for 93.6% of India's total meloxicam export value. The remaining 95 destination countries collectively receive the other 6.4%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Meloxicam to India?

11 origin countries · Total import value: $1.2M

India imports meloxicam from 11 countries with a combined import value of $1.2M. The largest supplier is UNITED STATES ($1.1M, 76 shipments), followed by GERMANY and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Meloxicam to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$1.1M	76	96.9%
2	GERMANY	$19.9K	4	1.7%
3	UNITED KINGDOM	$11.2K	6	0.9%
4	CANADA	$4.0K	8	0.3%
5	SINGAPORE	$1.2K	2	0.1%
6	BRAZIL	$516	1	0.0%
7	BULGARIA	$243	1	0.0%
8	MEXICO	$143	1	0.0%
9	SOUTH AFRICA	$93	3	0.0%
10	SAUDI ARABIA	$30	2	0.0%

Showing top 10 of 11 origin countries

UNITED STATES is the largest supplier of meloxicam to India, accounting for 96.9% of total import value. The top 5 origin countries — UNITED STATES, GERMANY, UNITED KINGDOM, CANADA, SINGAPORE — together supply 99.9% of India's meloxicam imports. Click any country to see detailed supplier and buyer data for that import corridor.

Meloxicam — Export Intelligence Video

Visual overview of India's meloxicam import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's meloxicam pharmaceutical import and export market — $199.4M in total trade, 277 verified manufacturers, and 100 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Meloxicam

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, meloxicam is approved for various indications, including the treatment of osteoarthritis and rheumatoid arthritis. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for meloxicam, indicating a competitive generic market. Notably, on August 11, 2005, the FDA approved Mobic (meloxicam) for the relief of signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients aged two years and older. This approval was granted to Avondale Pharmaceuticals, with orphan drug exclusivity expiring on August 11, 2012.

The substantial number of approved ANDAs reflects a well-established regulatory pathway for meloxicam in the U.S. market. The presence of 277 active Indian exporters underscores India's significant role in supplying meloxicam to the United States.

2EU & UK Regulatory Framework

In the European Union, meloxicam has been authorized for both human and veterinary use. For instance, Zynrelef, a combination of bupivacaine and meloxicam, received EU marketing authorization on September 24, 2020, for treating postoperative pain. However, this authorization was withdrawn on October 5, 2023, at the request of the marketing authorization holder, Heron Therapeutics, B.V., due to commercial reasons. (ema.europa.eu)

In the United Kingdom, meloxicam is authorized for veterinary use. For example, Meloxicam Ceva 0.5 mg/ml Oral Suspension for Cats was authorized on June 12, 2024, under the national authorization route. (vmd.defra.gov.uk)

Compliance with EU Good Manufacturing Practice (GMP) standards is mandatory for manufacturers exporting to these markets.

3WHO Essential Medicines & Global Standards

Meloxicam is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in global healthcare. It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, meloxicam is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates its price to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for exporting meloxicam formulations.

5Patent & Exclusivity Status

The primary patents for meloxicam have expired, leading to a competitive generic market globally. This has facilitated the entry of multiple manufacturers, including Indian exporters, into international markets.

6Recent Industry Developments

In October 2023, the European Commission withdrew the marketing authorization for Zynrelef (bupivacaine/meloxicam) in the EU at the request of Heron Therapeutics, B.V., due to commercial reasons. (ema.europa.eu)

In June 2024, the UK authorized Meloxicam Ceva 0.5 mg/ml Oral Suspension for Cats for veterinary use, reflecting ongoing regulatory activities in the veterinary sector. (vmd.defra.gov.uk)

These developments highlight the dynamic regulatory landscape for meloxicam, necessitating continuous monitoring by stakeholders.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Meloxicam

Retail & reference prices across 9 markets vs. India FOB export price of $1.58/unit

Global Price Benchmark for Meloxicam across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, Meloxicam is available as a generic medication, contributing to its low cost.
United Kingdom	$0.11	GBP	The NHS Drug Tariff lists Meloxicam 15mg tablets, indicating their availability and pricing within the NHS framework.
Germany	$0.10	EUR	The European Medicines Agency (EMA) has approved generic versions of Meloxicam, facilitating competitive pricing.
Australia	$0.11

Supply Chain Risk Assessment — Meloxicam

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Meloxicam, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of India's APIs and KSMs are sourced from China, underscoring a significant dependency on Chinese suppliers. This reliance exposes the supply chain to vulnerabilities stemming from geopolitical tensions, trade disputes, and regulatory changes in China.

In response to this dependency, the Indian government has initiated measures to bolster domestic API production. Notably, in October 2024, two greenfield plants were inaugurated under the Production Linked Incentive (PLI) scheme, aiming to manufacture critical molecules such as Penicillin G, 6-APA, and Clavulanic Acid. These efforts are intended to reduce import dependence by half for essential pharmaceutical ingredients. However, the effectiveness of these initiatives in mitigating risks associated with Meloxicam's supply chain remains to be fully realized.

2Supplier Concentration & Single-Source Risk

The export data for Meloxicam reveals a high supplier concentration, with the top five exporters accounting for 92.1% of total exports. UNICHEM LABORATORIES LIMITED alone holds a dominant 71.0% share, amounting to $141.5 million USD. This significant concentration poses a single-source risk, where disruptions affecting these key suppliers could severely impact the global availability of Meloxicam.

Access Complete Meloxicam Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,297 transactions across 100 markets.

Request Demo View Pricing

Frequently Asked Questions — Meloxicam Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top meloxicam exporters from India?

The leading meloxicam exporters from India are UNICHEM LABORATORIES LIMITED, CIPLA LIMITED, ZYDUS LIFESCIENCES LIMITED, and 12 others. UNICHEM LABORATORIES LIMITED leads with 71.0% market share ($141.5M). The top 5 suppliers together control 92.1% of total export value.

What is the total export value of meloxicam from India?

The total export value of meloxicam from India is $199.4M, recorded across 3,297 shipments from 277 active exporters to 100 countries. The average shipment value is $60.5K.

Which countries import meloxicam from India?

India exports meloxicam to 100 countries. The top importing countries are UNITED STATES (86.3%), SERBIA (3.0%), AUSTRALIA (1.6%), NIGERIA (1.5%), VIETNAM (1.3%), which together account for 93.6% of total export value.

What is the HS code for meloxicam exports from India?

The primary HS code for meloxicam exports from India is 30049066. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Meloxicam

Meloxicam

Top Meloxicam Exporters from India

Top Countries Importing Meloxicam from India

Who Supplies Meloxicam to India?

Quick Facts

Related Analgesics & Antipyretics

Related Analysis

Need Details?

Meloxicam — Export Intelligence Video

Regulatory Landscape — Meloxicam

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Meloxicam

Supply Chain Risk Assessment — Meloxicam

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Meloxicam Trade Intelligence

Frequently Asked Questions — Meloxicam Exports from India

Who are the top meloxicam exporters from India?

What is the total export value of meloxicam from India?

Which countries import meloxicam from India?

What is the HS code for meloxicam exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of meloxicam exports from India?

Which ports handle meloxicam exports from India?

Why is India a leading exporter of meloxicam?

What certifications do Indian meloxicam exporters need?

How many buyers import meloxicam from India?

What is the market share of the top meloxicam exporter from India?

Analysis Methodology